HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors

Taimur Khalid; Hazem Aboaid; Daniel Thomas Jones; Jason Ta; Ramaditya Srinivasmurthy; Kenny Do; Kevin Nguyen; Karina Fama; Rishi Kumar Nanda; Sarah Aamer; Jo Lawrence Bigcas; Kyaw Zin Thein

doi:10.6004/jnccn.2024.7329

HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors

Taimur Khalid
, Hazem Aboaid
, Daniel Thomas Jones
, Jason Ta
, Ramaditya Srinivasmurthy
, Kenny Do
, Kevin Nguyen
, Karina Fama
, Rishi Kumar Nanda
, Sarah Aamer
, Jo Lawrence Bigcas
, Kyaw Zin Thein

Research output: Contribution to journal › Article › peer-review

Original language	English (UK)
Journal	Journal of the National Comprehensive Cancer Network : JNCCN
Volume	23
Issue number	35
DOIs	https://doi.org/10.6004/jnccn.2024.7329
Publication status	Published - 28 Mar 2025
Externally published	Yes

Access to Document

10.6004/jnccn.2024.7329

Cite this

Khalid, T., Aboaid, H., Jones, D. T., Ta, J., Srinivasmurthy, R., Do, K., Nguyen, K., Fama, K., Nanda, R. K., Aamer, S., Bigcas, J. L., & Thein, K. Z. (2025). HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network : JNCCN, 23(35). https://doi.org/10.6004/jnccn.2024.7329

Khalid, Taimur ; Aboaid, Hazem ; Jones, Daniel Thomas et al. / HSR25-186 : A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. In: Journal of the National Comprehensive Cancer Network : JNCCN. 2025 ; Vol. 23, No. 35.

@article{5d3fa958994c4d42bd69f3a418296ad0,

title = "HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors",

author = "Taimur Khalid and Hazem Aboaid and Jones, \{Daniel Thomas\} and Jason Ta and Ramaditya Srinivasmurthy and Kenny Do and Kevin Nguyen and Karina Fama and Nanda, \{Rishi Kumar\} and Sarah Aamer and Bigcas, \{Jo Lawrence\} and Thein, \{Kyaw Zin\}",

year = "2025",

month = mar,

day = "28",

doi = "10.6004/jnccn.2024.7329",

language = "English (UK)",

volume = "23",

journal = "Journal of the National Comprehensive Cancer Network : JNCCN",

issn = "1540-1405",

publisher = "Harborside Press",

number = "35",

}

Khalid, T, Aboaid, H, Jones, DT, Ta, J, Srinivasmurthy, R, Do, K, Nguyen, K, Fama, K, Nanda, RK, Aamer, S, Bigcas, JL & Thein, KZ 2025, 'HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors', Journal of the National Comprehensive Cancer Network : JNCCN, vol. 23, no. 35. https://doi.org/10.6004/jnccn.2024.7329

HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. / Khalid, Taimur; Aboaid, Hazem; Jones, Daniel Thomas et al.
In: Journal of the National Comprehensive Cancer Network : JNCCN, Vol. 23, No. 35, 28.03.2025.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - HSR25-186

T2 - A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors

AU - Khalid, Taimur

AU - Aboaid, Hazem

AU - Jones, Daniel Thomas

AU - Ta, Jason

AU - Srinivasmurthy, Ramaditya

AU - Do, Kenny

AU - Nguyen, Kevin

AU - Fama, Karina

AU - Nanda, Rishi Kumar

AU - Aamer, Sarah

AU - Bigcas, Jo Lawrence

AU - Thein, Kyaw Zin

PY - 2025/3/28

Y1 - 2025/3/28

UR - https://www.scopus.com/pages/publications/105002548933

U2 - 10.6004/jnccn.2024.7329

DO - 10.6004/jnccn.2024.7329

M3 - Article

C2 - 40159142

AN - SCOPUS:105002548933

SN - 1540-1405

VL - 23

JO - Journal of the National Comprehensive Cancer Network : JNCCN

JF - Journal of the National Comprehensive Cancer Network : JNCCN

IS - 35

ER -

Khalid T, Aboaid H, Jones DT, Ta J, Srinivasmurthy R, Do K et al. HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors. Journal of the National Comprehensive Cancer Network : JNCCN. 2025 Mar 28;23(35). doi: 10.6004/jnccn.2024.7329

HSR25-186: A Systematic Review and Meta-Analysis of Randomized Controlled Trials to Evaluate the Risk of General Systemic Adverse Events in Locally Advanced Head and Neck Squamous Cell Carcinoma Treated With Immune Checkpoint Inhibitors

Access to Document

Other files and links

Cite this